Background Experimental studies and small clinical trials have suggested that treatment with
intranasal oxytocin may reduce social impairment in persons with autism spectrum disorder…

Background Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder characterized
by psychiatric and neurological features. Most reported cases are caused by 22q13.3 …

Background The current study used eye tracking to investigate attention and recognition
memory in Phelan-McDermid syndrome (PMS), a rare genetic disorder characterized by …

The Social Responsiveness Scale‐2 (SRS‐2) is a quantitative measure used to characterize
symptoms of autism spectrum disorder (ASD). However, research suggests that SRS‐2 …

Oxytocin (OT), the brain's most abundant neuropeptide, plays an important role in social
salience and motivation. Clinical trials of the efficacy of OT in autism spectrum disorder (ASD) …

Objective The current study used visual evoked potentials (VEPs) to examine excitatory and
inhibitory postsynaptic activity in children with Phelan-McDermid syndrome (PMS) and the …

Large-scale genomic studies have identified over 100 genes associated with autism spectrum
disorder (ASD); however, important phenotypic variables are captured inconsistently. In …

Despite growing public awareness of ASD, many caregivers of children with ASD struggle to
find opportunities for participation in community activities with appropriate accommodations. …

Background Excitatory/inhibitory imbalance represents one promising mechanistic
hypothesis for autism spectrum disorder (ASD). Impairments in excitatory (glutamatergic) and …

BACKGROUND: Experimental studies and small clinical trials have suggested that treatment
with intranasal oxytocin may reduce social impairment in persons with autism spectrum …